83 related articles for article (PubMed ID: 12491799)
21. Relationships between conformational behaviour and binding affinity towards beta 1 and beta 2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents.
Villa L; Villa AM; Pallavicini M; Romeo S; Valoti E; Ferri V; Iuliano E; Brunello N
Farmaco; 1995 Oct; 50(10):643-58. PubMed ID: 8590572
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
24. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
Zhong H; Minneman KP
Mol Pharmacol; 1993 Dec; 44(6):1085-93. PubMed ID: 7903414
[TBL] [Abstract][Full Text] [Related]
25. β(3)-Adrenoceptor agonists and (antagonists as) inverse agonists history, perspective, constitutive activity, and stereospecific binding.
Grazia Perrone M; Scilimati A
Methods Enzymol; 2010; 484():197-230. PubMed ID: 21036234
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
Maruyama T; Onda K; Hayakawa M; Matsui T; Takasu T; Ohta M
Eur J Med Chem; 2009 Jun; 44(6):2533-43. PubMed ID: 19232786
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and beta 1-, beta 2-adrenergic receptor binding studies of 4-acylamino-substituted phenoxypropanolamine and 5-acylamino-substituted naphthyloxypropanolamine derivatives.
Jindal DP; Coumar MS; Bruni G; Massarelli P
Arzneimittelforschung; 2002; 52(9):654-63. PubMed ID: 12404879
[TBL] [Abstract][Full Text] [Related]
28. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors.
Konkar AA; Nikulin VI; De Los Angeles J; Hong SS; Fertel RH; Miller DD; Feller DR
Pharmacology; 2001 Jan; 62(1):45-55. PubMed ID: 11150922
[TBL] [Abstract][Full Text] [Related]
29. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of novel phenylethanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
Maruyama T; Onda K; Hayakawa M; Suzuki T; Kimizuka T; Matsui T; Takasu T; Nagase I; Hamada N; Ohta M
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):533-45. PubMed ID: 20410638
[TBL] [Abstract][Full Text] [Related]
31. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
[TBL] [Abstract][Full Text] [Related]
32. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
33. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
[TBL] [Abstract][Full Text] [Related]
34. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
[TBL] [Abstract][Full Text] [Related]
35. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
Devic E; Xiang Y; Gould D; Kobilka B
Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
[TBL] [Abstract][Full Text] [Related]
36. Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.
Konkar AA; Vansal SS; Shams G; Fraundorfer PF; Zheng WP; Nikulin VI; De Los Angeles J; Fertel RH; Miller DD; Feller DR
J Pharmacol Exp Ther; 1999 Nov; 291(2):875-83. PubMed ID: 10525112
[TBL] [Abstract][Full Text] [Related]
37. Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
Perrone MG; Santandrea E; Bleve L; Vitale P; Colabufo NA; Jockers R; Milazzo FM; Sciarroni AF; Scilimati A
Bioorg Med Chem; 2008 Mar; 16(5):2473-88. PubMed ID: 18083578
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
39. Role of beta1-, beta2-, and beta3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation.
Rickenbacher A; Seiler R; Honegger U; Shaw SG; Balsiger BM
Surgery; 2008 Jan; 143(1):94-102. PubMed ID: 18154937
[TBL] [Abstract][Full Text] [Related]
40. The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome.
Masunaga K; Chapple CR; McKay NG; Yoshida M; Sellers DJ
Neurourol Urodyn; 2010 Sep; 29(7):1320-5. PubMed ID: 20151470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
